...
首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3.
【24h】

Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3.

机译:使用针对神经节苷脂GD1a,GT1b和GM3的IgM抗体进行感觉运动性脱髓鞘神经病。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report a patient with sensorimotor demyelinating neuropathy with high-titer IgM antibody against gangliosides GD1a, GT1b and GM3. The patient was a 65-year-old male who was hospitalized with chief complaints of muscular weakness of all limbs and numbness of the hands and feet. Nerve-conduction studies revealed reduced conduction velocities of the motor nerves with increased temporal dispersion and loss of sensory nerve action potentials. Treatment with steroids was ineffective. IgM antibody against GD1a, GT1b and GM3, which are known to be the ligands for myelin-associated glycoprotein (MAG), might have played a role in the demyelination in this patient by inhibiting adhesion between myelin and axonal membrane.
机译:我们报告了一个患者,对神经节苷脂GD1a,GT1b和GM3的高滴度​​IgM抗体伴感觉运动性脱髓鞘神经病。该患者是一名65岁的男性,因主诉四肢肌肉无力和手脚麻木而住院。神经传导研究显示运动神经传导速度降低,时间散布增加,感觉神经动作电位丧失。用类固醇治疗无效。抗GD1a,GT1b和GM3的IgM抗体可能是髓鞘相关糖蛋白(MAG)的配体,可能通过抑制髓鞘与轴突膜之间的粘附而在该患者的脱髓鞘中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号